Cyclophosphamide (BioCAD00000009154)
{$topic}
Metabolite Card
Formula: C7H15Cl2N2O2P. H2O (278.0354)
SMILES: C1CNP(=O)(OC1)N(CCCl)CCCl.O
Synonyms [en]
Cyclophosphamide hydrate; Cyclophosphamide; CYCLOPHOSPHAMIDUM [WHO-IP LATIN]; Endoxan; CYCLOPHOSPHAMIDE [USP MONOGRAPH]; 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, monohydrate, (+-)
Last reviewed on 2024-06-28.
Cite this Page
Cyclophosphamide. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000009154). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
Cyclophosphamide monohydrate appears as fine white crystalline powder with a slightly bitter taste. Little or no odor. (NTP, 1992) Cyclophosphamide hydrate is the monohydrate of cyclophosphamide. It has a role as an antineoplastic agent, an immunosuppressive agent, an alkylating agent and a carcinogenic agent. It contains a cyclophosphamide. Cyclophosphamide is a synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.
DBLinks
- CAS Registry Number: 6055-19-2
- PubChem CID: 22420
- ChEBI: 4026
- HMDB:
- LipidMaps:
- KEGG: C06933
- BioCyc:
- NCBI MeSH: Cyclophosphamide
- Wikipedia:
Other DBLinks
- CAS Registry Number: 6055-19-2
- PubChem: 22420
- ChEBI: ChEBI:4026
- KEGG: C06933
- NCBI MeSH: Cyclophosphamide
Class / Ontology
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| Reactome:R-BTA-1430728 | Metabolism |
| Reactome:R-BTA-211945 | Phase I - Functionalization of compounds |
| Reactome:R-BTA-211981 | Xenobiotics |
| Reactome:R-CEL-211859 | Biological oxidations |
| Reactome:R-CEL-211981 | Xenobiotics |
| Reactome:R-CFA-1430728 | Metabolism |
| Reactome:R-DRE-211897 | Cytochrome P450 - arranged by substrate type |
| Reactome:R-DDI-211859 | Biological oxidations |
| Reactome:R-DDI-211981 | Xenobiotics |
| Reactome:R-HSA-211859 | Biological oxidations |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-211859 | Biological oxidations |
| Reactome:R-RNO-211945 | Phase I - Functionalization of compounds |
| Reactome:R-RNO-211981 | Xenobiotics |
| Reactome:R-SSC-211945 | Phase I - Functionalization of compounds |
| Reactome:R-SSC-211981 | Xenobiotics |
| Reactome:R-XTR-211897 | Cytochrome P450 - arranged by substrate type |
| Reactome:R-BTA-211859 | Biological oxidations |
| Reactome:R-CFA-211897 | Cytochrome P450 - arranged by substrate type |
| Reactome:R-DRE-211945 | Phase I - Functionalization of compounds |